A recognized subset of patients with non-small cell lung cancer (NSCLC) harbor actionable genomic aberrations that can benefit from targeted therapy. In lung cancer, epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are well characterized oncogenic ...
1例EGFR野生型肺腺癌的靶向治疗 Targeted therapy for EGFR wild-type lung adenocarcinoma: A case report 作者:刘斌,黄彭,刘双柏,梁彦超,谢波 中国是肺癌大国,其发病率和病死率均位居所有恶性肿瘤的首位。而晚期肺癌传统治疗手段 主要为放化疗。IPASS研究结果显示:EGFR...
[10]Chen H, Liu M, Dai Z, et al. Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma. Transl Lung Cancer Res. 2020 Aug;9(4):1225-1234. DOI: 10.21037/tlcr-20-679 [11] Roeper J, Falk M, Chalaris-Rißmann A, ...
[1]. Chan, B.A. and B.G. Hughes, Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res, 2015. 4(1): p. 36-54. [2]. Costa, D.B., Kinase inh...
2021年2月,靶向治疗领域著名期刊Signal Transduction and Targeted Therapy(IF=13.5)在线发表了题为“The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer”的研究[1]。广州医科大学附属第一医院、广州呼吸健康研究院、国家呼吸医学中心何建行教授、梁文华教...
[6] Wang Q, Yang S, Wang K and Sun SY: MET inhibitors for targeted therapy of EGFR TKI‑resistant lung cancer. J Hematol Oncol 12: 63, 2019. [7] Drilon A, Cappuzzo F, Ou SI and Camidge DR: Targeting MET in lung cancer: Will expectations finally Be MET? J Thorac Oncol 12: ...
[2] Chan BA, Hughes BG. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res. 2015;4:36–54. [3] Castellanos E,Feld E,Horn L.Driven by mutations:the predictive value of mutation subtype in EGFR-mutated non-small cell...
[1]. Chan, B.A. and B.G. Hughes, Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res, 2015. 4(1): p. 36-54. [2]. Costa, D.B., Kinase inhibitor-responsive genotypes in EGFR mutated lung adenocarcinomas: moving...
3. Chan, B.A. and B. Hughes,Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future.Translational Lung Cancer Research, 2014. 4. 于国华, 董丽萍, and 刘淑真,EGFR基因突变与吉非替尼的疗效和获得性耐药关系的研究概况.中华肿瘤防治杂志, 2007.14(6): p. ...
2021年2月,靶向治疗领域著名期刊Signal Transduction and Targeted Therapy(IF=13.5)在线发表了题为“The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer”的研究[1]。广州医科大学附属第一医院、广州呼吸健康研究院、国家呼吸医学中心何建行教授、梁文华教授为共同...